Today: 7 February 2026
Subscribe

Costco Stock (COST) on December 5, 2025: Sales Strength, Slowing U.S. Momentum, Board Shake-Up and 2026–2030 Forecasts

Costco Stock (COST) on December 5, 2025: Sales Strength, Slowing U.S. Momentum, Board Shake-Up and 2026–2030 Forecasts

Costco Wholesale Corporation (NASDAQ: COST) is back in focus after a volatile week in which strong November sales, a surprise board nomination and fresh talk of special dividends met growing worries about slowing U.S. momentum and a rich valuation. As of mid‑afternoon on Friday, December 5, 2025, Costco shares trade around $904 per share, up modestly on the day but still well below their 52‑week high near $1,080.MarketBeat After a ~3% drop on Thursday, the stock has turned negative for 2025, lagging far behind the S&P 500’s double‑digit gain this year.MarketWatch Below is a detailed breakdown of the latest news,
5 December 2025
AppLovin (APP) Stock on 5 December 2025: AI Rocket, SEC Clouds and What Wall Street Expects Next

AppLovin (APP) Stock on 5 December 2025: AI Rocket, SEC Clouds and What Wall Street Expects Next

AppLovin Corporation (NASDAQ: APP) has turned into one of the most explosive large‑cap stocks in the U.S. market – and one of the most controversial. As of 5 December 2025, shares trade in the high‑$600s, up well over 1,700% in the past 24 months, making AppLovin the best‑performing large‑cap U.S. stock over that period. StatMuse At the same time, the company faces an SEC investigation into its data practices, heavy insider selling and a valuation that many analysts already call “rich.” This article pulls together today’s price action, the latest earnings, fresh Wall Street forecasts and key bull and bear
5 December 2025
·
Eli Lilly (LLY) Stock Outlook: Can the Obesity-Drug Giant Keep Justifying a $1,000 Share Price?

Eli Lilly (LLY) Stock Outlook: Can the Obesity-Drug Giant Keep Justifying a $1,000 Share Price?

Updated: December 5, 2025 Eli Lilly and Company (NYSE: LLY) remains one of the most closely watched stocks in global markets as investors weigh eye‑popping growth in obesity and diabetes drugs against equally eye‑popping valuations and rising political pressure on drug prices. On December 5, 2025, Lilly shares are trading just above the $1,000 mark after recently touching an historic $1 trillion market capitalization, the first time a healthcare company has reached that milestone.CoinCentral At the same time, the company is cutting prices on flagship obesity drug Zepbound, navigating new U.S. “most‑favored‑nation” pricing rules, and preparing to ask regulators for
5 December 2025
··
Comcast Stock (CMCSA) Rises as Versant Spin-Off Nears: Latest News, Analyst Targets, and 2026 Outlook

Comcast Stock (CMCSA) Rises as Versant Spin-Off Nears: Latest News, Analyst Targets, and 2026 Outlook

Comcast stock (CMCSA) is trading in the high‑$20s as the company moves ahead with its Versant Media Group spin‑off, digests mixed broadband trends, and faces sharply divided analyst opinions. Here’s the full picture as of December 5, 2025. Comcast stock on 5 December 2025: where things stand As of mid‑session on Friday, December 5, 2025, Comcast Corporation Class A shares (Nasdaq: CMCSA) were trading around $27.81, up roughly 2.2% on the day. The stock has moved off its recent 52‑week low near $25.75 but remains far below a one‑year high around $43.30. MarketBeat Over the past year, Comcast shares have
5 December 2025
··
Intel Stock Today: Apple Foundry Rumors, $208M Malaysia Bet and a U‑Turn on NEX – What It All Means for INTC Investors (5 December 2025)

Intel Stock Today: Apple Foundry Rumors, $208M Malaysia Bet and a U‑Turn on NEX – What It All Means for INTC Investors (5 December 2025)

Intel Corporation (NASDAQ: INTC) is closing out 2025 as one of the market’s most dramatic turnaround stories. After being left for dead during the 2022–2024 slump, the chipmaker’s share price has roughly doubled this year, driven by massive government and strategic investments, renewed confidence in its manufacturing roadmap, and fresh speculation about Apple returning as a customer.Forbes+1 On 5 December 2025, Intel stock is trading around the low‑$40s (about $42–43 per share), rebounding from a 7.4% slide the previous day that briefly knocked the price down to roughly $40.50.MarketBeat Volatility is elevated as investors digest a cluster of big headlines:
5 December 2025
·
Parsons Corporation (PSN) Stock Plunges After FAA Contract Loss: What December 5, 2025 Means for the Outlook

Parsons Corporation (PSN) Stock Plunges After FAA Contract Loss: What December 5, 2025 Means for the Outlook

Updated: December 5, 2025 Parsons Corporation (NYSE: PSN) is having one of its most volatile trading days since going public. After months of anticipation, the U.S. Federal Aviation Administration (FAA) chose rival Peraton—not Parsons—as the prime integrator for the massive “Brand New Air Traffic Control System” (BNATCS) overhaul. In late‑morning trading on Friday, December 5, 2025, Parsons stock was changing hands around $64 per share, down roughly 24% from Thursday’s close of $84.46, putting the name firmly among the day’s biggest decliners. StockAnalysis+1 Yet, on the same day, Parsons announced it had been selected for a $3.5 billion Defense Threat
5 December 2025
·
Oracle (ORCL) Stock Today: AI Cloud Backlog, Debt Warnings and What to Expect from Dec. 10 Earnings

Oracle (ORCL) Stock Today: AI Cloud Backlog, Debt Warnings and What to Expect from Dec. 10 Earnings

Oracle Corporation (NYSE: ORCL) is back in the spotlight on December 5, 2025, as its stock rebounds in pre‑market trading while Wall Street debates whether the company is a generational AI infrastructure winner or a highly leveraged credit risk. As of late morning on December 5, Oracle shares trade around $217 per share, modestly higher on the day and up roughly 3% from Wednesday’s close, giving the company a market value of about $610 billion.MarketBeat That move follows a 3.18% pre‑market jump earlier in the session, driven by renewed optimism around Oracle’s AI‑driven cloud strategy.AInvest The stakes are high: Oracle
5 December 2025
····
Praxis Precision Medicines (PRAX) Soars on FDA Momentum and Epilepsy Breakthroughs as Stock Hits New High on December 5, 2025

Praxis Precision Medicines (PRAX) Soars on FDA Momentum and Epilepsy Breakthroughs as Stock Hits New High on December 5, 2025

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) extended its remarkable 2025 rally on Friday, December 5, with shares surging almost 40% intraday after the company reported a double dose of good news: a pivotal epilepsy trial stopped early for efficacy and a positive pre-NDA meeting with the U.S. Food and Drug Administration (FDA) for its lead essential tremor drug. StockAnalysis+3TradingView+3Stock Titan+3 By late morning U.S. trading, PRAX was changing hands around $265–266, up roughly 40% on the day, with a market capitalization just over $1.1 billion, after hitting a new 52‑week high earlier in the session near $241. Investing.com+1 The stock
5 December 2025
MP Materials Stock (NYSE: MP): Morgan Stanley Upgrade, Saudi JV and a 41% Pullback – December 5, 2025 Update

MP Materials Stock (NYSE: MP): Morgan Stanley Upgrade, Saudi JV and a 41% Pullback – December 5, 2025 Update

MP Materials Corp (NYSE: MP) is closing out 2025 as one of the wildest rides in the S&P 500. After a year of government mega‑deals, geopolitical headlines and soaring rare‑earth prices, the stock now sits roughly 40% below its early‑year high but hundreds of percent above where it started the year. Simply Wall St+1 On December 5, 2025, the story added a fresh chapter: Morgan Stanley upgraded MP Materials to Overweight, a new batch of analyst targets landed in the $70–$80 range, and several in‑depth valuation pieces questioned whether the stock is now a strategic bargain or a speculative bubble.
5 December 2025
Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) has suddenly landed back on traders’ radars. After months of drifting as a tiny, cash‑rich micro‑cap biotech, the stock exploded higher at the start of December 2025 – just weeks after the company killed its lead drug program and launched a strategic review. This article walks through the latest SNSE stock price moves, the full 2025 news timeline, the strategic review, analyst forecasts, and the key risks around this highly speculative name. It is informational only and not investment advice. SNSE stock price today: how high did Sensei Biotherapeutics jump? As of the regular session
5 December 2025
··
Akanda Corp (AKAN) Stock Soars After Shareholder Vote: Reverse Merger, Mexico Towers and 2025–2030 Forecasts

Akanda Corp (AKAN) Stock Soars After Shareholder Vote: Reverse Merger, Mexico Towers and 2025–2030 Forecasts

Published: December 5, 2025 Akanda Corp’s Nasdaq-listed shares (ticker: AKAN) are back in the spotlight after a dramatic late‑week move. On Thursday evening, the micro‑cap stock surged about 45% in after‑hours trading to roughly $1.37, after the company disclosed that shareholders had approved sweeping capital‑structure changes linked to its reverse merger with First Towers & Fiber Corp and a package of convertible debt. Benzinga+2Stock Titan+2 The spike caps a volatile stretch in 2025 during which Akanda has tried to reinvent itself from a tiny, loss‑making medical cannabis company into a hybrid telecom‑infrastructure and cannabis play with operations in Mexico and
5 December 2025
···
SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast

SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast

SciSparc Ltd. (NASDAQ: SPRC) is back on traders’ radar after a frenetic week of news that spans quantum bio‑data analytics, medical endoscopy devices and ongoing restructuring of its biotech portfolio. As of Friday, December 5, 2025, SciSparc shares are trading around $1.79–$1.80, after an early pre‑market jump of about 19% to $2.10, on volume that has already surged well above normal levels. StockAnalysis+1 Despite today’s bounce, the stock remains down roughly 60–75% over the past year and more than 95% below its 52‑week high of $37.59, leaving the company with a micro‑cap market value of roughly $5.6–$5.9 million. INDmoney+2Stock Titan+2
5 December 2025
··
AMD Stock (Advanced Micro Devices) in December 2025: Latest AI News, China Tax Deal and Wall Street Price Forecast

AMD Stock (Advanced Micro Devices) in December 2025: Latest AI News, China Tax Deal and Wall Street Price Forecast

Advanced Micro Devices Inc. (NASDAQ: AMD) remains one of the most closely watched AI and semiconductor stocks as of December 5, 2025. With fresh headlines about AI chips, export taxes on China shipments and bold long‑term forecasts, AMD stock is back in focus for traders and long‑term investors alike. As of mid‑day on December 5, 2025, AMD shares trade around $219 per share, within a day range of roughly $214–$219 and a 52‑week range of about $76–$267. Over the last year, the stock is up around 56%, underscoring both strong gains and high volatility in the AI chip trade. Yahoo
5 December 2025
·
Micron Technology (MU) Stock Outlook Today: AI Memory Supercycle, Crucial Exit and 2026 Price Targets — December 5, 2025

Micron Technology (MU) Stock Outlook Today: AI Memory Supercycle, Crucial Exit and 2026 Price Targets — December 5, 2025

Micron Technology, Inc. (NASDAQ: MU) has become one of 2025’s defining AI winners. The memory-chip specialist is up around 170–180% year‑to‑date, as investors bet that the “AI memory supercycle” will deliver years of elevated growth, margins and cash flow. Nasdaq+1 As of early afternoon on December 5, 2025, Micron shares trade around $230 (last trade roughly $230.37), after a volatile week that saw the stock sell off on news that the company will shut down its consumer-facing Crucial brand to focus even more aggressively on high‑bandwidth memory (HBM) and AI data centers. Finviz Below is a deep dive into the
5 December 2025
Netflix (NFLX) Stock on December 5, 2025: Warner Bros Mega‑Deal, Post‑Split Price, and 2026 Forecast

Netflix (NFLX) Stock on December 5, 2025: Warner Bros Mega‑Deal, Post‑Split Price, and 2026 Forecast

Updated: December 5, 2025 Netflix, Inc. (NASDAQ: NFLX) is trading lower today as Wall Street digests a historic $72 billion bid for Warner Bros. Discovery’s studios and streaming business, fresh regulatory risk, and still‑strong but imperfect fundamentals after a recent 10‑for‑1 stock split. Reuters Key takeaways Netflix stock today: price, performance and volatility As of this afternoon on December 5, 2025, Netflix shares change hands at about $101.17, down roughly 2% on the session. The stock opened near $98.7, has traded between $97.9 and $103, and volume is elevated as traders react to the Warner Bros announcement. Looking at the
5 December 2025
··
Broadcom (AVGO) Stock on December 5, 2025: AI Chip Deals, Analyst Upgrades and 2026 Forecasts

Broadcom (AVGO) Stock on December 5, 2025: AI Chip Deals, Analyst Upgrades and 2026 Forecasts

Date: December 5, 2025 – Analysis of Broadcom Inc. (NASDAQ: AVGO) stock, news and forecasts This article is for informational purposes only and does not constitute investment advice. Broadcom Stock Today: Price, Valuation and Trading Context Broadcom (NASDAQ: AVGO) enters the final month of 2025 trading close to record territory. The stock closed on December 4 at about $381 per share, with pre‑market quotes on December 5 showing AVGO in the mid‑$380s, nudging higher ahead of the open.StockAnalysis+1 At these levels, Broadcom’s market capitalization is roughly $1.8 trillion, placing it firmly among the world’s most valuable semiconductor and software companies.
5 December 2025
·
Alphabet (GOOG) Stock Today: AI Momentum, Berkshire’s Big Bet and Fresh $400 Price Targets – 5 December 2025

Alphabet (GOOG) Stock Today: AI Momentum, Berkshire’s Big Bet and Fresh $400 Price Targets – 5 December 2025

Alphabet Inc. Class C stock (NASDAQ: GOOG) is trading near record highs as investors digest a powerful mix of AI breakthroughs, blowout earnings, and fresh Wall Street upgrades. As of early trading around December 5, 2025, GOOG is hovering close to $318 per share, just below its late‑November all‑time high near $329, giving Alphabet a market value of roughly $2.9 trillion. At the same time, regulators in the U.S. and Europe are tightening the screws on Google’s ad and search businesses, and analysts are increasingly debating how much of the AI boom is already priced in. This article pulls together
5 December 2025
·
Snowflake (SNOW) Stock Falls After Q3 Beat: AI Deals, Analyst Targets and Outlook as of December 5, 2025

Snowflake (SNOW) Stock Falls After Q3 Beat: AI Deals, Analyst Targets and Outlook as of December 5, 2025

Snowflake Inc. (NYSE: SNOW) is back in the spotlight after a sharp post‑earnings selloff, even as the cloud data platform continues to post strong growth and headline‑grabbing AI partnerships. On December 5, 2025, investors are weighing a classic growth‑stock dilemma: solid fundamentals and powerful AI tailwinds on one side, and rich valuations plus slowing growth and margin pressure on the other. Key Takeaways Snowflake Stock Today: Price, Valuation and 52‑Week Context As of mid‑day trading on December 5, 2025, Snowflake shares change hands at roughly $229–$230, down modestly on the day after Thursday’s steep drop.StockAnalysis Key snapshot metrics: Even after
5 December 2025
··
Best UK Stocks to Buy Now (5 December 2025): 10 Shares to Watch as the FTSE 100 Nears Record Highs

Best UK Stocks to Buy Now (5 December 2025): 10 Shares to Watch as the FTSE 100 Nears Record Highs

As of 5 December 2025, UK equities are quietly having one of their best years in over a decade. The FTSE 100 is up around 22–23% year-to-date (including dividends) and sits less than 2% below its record closing high, according to analysis from AJ Bell and Investing.com. MoneyWeek+1 Today, the FTSE 100 is up about 0.2% and the FTSE 250 about 0.4%, with AstraZeneca, Ocado, Watches of Switzerland and Greggs among the day’s notable risers, while energy majors BP and Shell drag on the index. ReutersAt the same time, markets are betting that the Bank of England will cut Bank Rate from 4% to 3.75% on 18 December, with economists expecting
5 December 2025
·······
Best ASX Stocks to Buy Now (5 December 2025): Top Australian Shares for AI, Resources and Dividends

Best ASX Stocks to Buy Now (5 December 2025): Top Australian Shares for AI, Resources and Dividends

This article is general information only and is not personal financial advice. Always do your own research or speak with a licensed adviser before investing. 1. What’s happening on the Australian stock market today? The S&P/ASX 200 closed up 0.19% at 8,634.60 on 5 December 2025, with gains led by materials, financials and technology, while consumer discretionary and energy lagged. Big movers included BHP, Fortescue, lithium stocks like IGO and Mineral Resources, and tech names such as Life360 and NextDC. News.com.au Intraday commentary from Market Index shows the index effectively finishing the week flat, as strong resource stocks were offset by renewed interest‑rate worries. The
5 December 2025
·······
1 … 1,095 1,096 1,097 1,098 1,099 … 1,631

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop